Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland have?
Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland has 49 citations in the OpenAlex counts ScholarIQ stores.
When was Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland published?
Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland has 2012 year in the ScholarIQ index.
What is the open-access status of Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland?
Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland has diamond oa status in the ScholarIQ index.
What is the DOI of Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland?
The DOI for Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland is on the source record.
What is the PMID of Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland?
The PMID for Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland is on the source record.
What is the OpenAlex record for Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland?
The OpenAlex for Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland is on the source record.